New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Learn More
Last Close
Sep 17  •  04:00PM ET
1.90
Dollar change
-0.06
Percentage change
-3.06
%
Index- P/E- EPS (ttm)-0.76 Insider Own36.97% Shs Outstand62.06M Perf Week-7.77%
Market Cap123.54M Forward P/E- EPS next Y-0.78 Insider Trans0.00% Shs Float40.98M Perf Month9.20%
Enterprise Value-17.75M PEG- EPS next Q-0.18 Inst Own42.68% Short Float1.04% Perf Quarter66.67%
Income-65.43M P/S- EPS this Y-20.48% Inst Trans-28.20% Short Ratio0.68 Perf Half Y42.86%
Sales0.00M P/B0.94 EPS next Y-8.30% ROA-37.68% Short Interest0.43M Perf YTD-24.00%
Book/sh2.03 P/C0.80 EPS next 5Y-9.60% ROE-46.33% 52W High5.07 -62.52% Perf Year-48.65%
Cash/sh2.38 P/FCF- EPS past 3/5Y- - ROIC-51.96% 52W Low0.97 95.88% Perf 3Y-80.77%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility7.25% 7.28% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM-50.20% Oper. Margin- ATR (14)0.14 Perf 10Y-
Dividend Ex-Date- Quick Ratio8.40 Sales Y/Y TTM- Profit Margin- RSI (14)48.83 Recom1.29
Dividend Gr. 3/5Y- - Current Ratio8.40 EPS Q/Q-0.36% SMA20-6.73% Beta-0.02 Target Price13.33
Payout- Debt/Eq0.00 Sales Q/Q- SMA508.99% Rel Volume0.32 Prev Close1.96
Employees30 LT Debt/Eq0.00 EarningsAug 14 BMO SMA20018.48% Avg Volume629.35K Price1.90
IPOSep 03, 2021 Option/ShortYes / Yes EPS/Sales Surpr.9.72% - Trades Volume203,157 Change-3.06%
Date Action Analyst Rating Change Price Target Change
Nov-04-24Initiated Leerink Partners Outperform $15
Sep-05-24Initiated H.C. Wainwright Neutral $5
May-03-24Initiated Piper Sandler Overweight $26
Oct-10-23Initiated Ladenburg Thalmann Buy $10
Aug-25-23Initiated Oppenheimer Outperform $17
Jun-22-23Initiated Guggenheim Buy $20
Jun-14-23Initiated Chardan Capital Markets Buy $14
May-24-23Initiated Raymond James Strong Buy $20
Aug-20-25 06:30AM
Aug-14-25 08:15AM
Jul-17-25 04:30PM
Jul-01-25 06:30AM
May-27-25 06:30AM
06:30AM Loading…
May-20-25 06:30AM
May-08-25 06:30AM
Mar-25-25 06:30AM
Feb-24-25 06:30AM
Dec-23-24 06:30AM
Nov-25-24 06:30AM
Nov-14-24 04:30PM
Nov-07-24 06:30AM
Oct-30-24 06:30AM
Sep-03-24 06:00AM
09:21AM Loading…
Aug-13-24 09:21AM
Aug-12-24 04:05PM
Aug-09-24 04:05PM
Aug-01-24 08:00AM
Jul-12-24 06:10AM
06:08AM
Jun-14-24 06:00AM
Jun-06-24 06:00AM
Jun-03-24 06:00AM
May-31-24 09:55AM
May-29-24 06:00AM
May-24-24 06:18AM
May-15-24 09:55AM
May-14-24 12:00PM
May-12-24 03:26PM
03:14PM Loading…
May-10-24 03:14PM
May-09-24 01:56PM
06:00AM
Apr-25-24 02:18AM
Apr-18-24 09:22AM
Apr-08-24 06:00AM
Mar-28-24 11:54AM
06:00AM
Mar-04-24 06:00AM
Feb-02-24 06:00AM
Jan-08-24 06:00AM
Jan-03-24 06:00AM
Dec-04-23 06:00AM
Nov-14-23 06:00AM
Nov-13-23 06:30AM
Sep-12-23 05:00AM
Sep-05-23 08:55PM
Aug-25-23 09:42AM
Aug-14-23 07:00AM
Jun-23-23 06:30AM
Jun-06-23 06:34AM
04:00AM
Jun-01-23 10:20AM
Apr-27-23 07:39AM
Apr-14-23 05:00AM
Mar-27-23 09:35AM
Mar-21-23 06:13AM
Zura Bio Ltd. is a clinical-stage biotechnology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thiara ParvinderDirectorNov 25 '24Sale2.731,001,6332,734,4580Nov 27 04:15 PM